NCT03768193

Brief Summary

Thoracic surgery, and surgery involving the chest wall in general, is associated with poorly controlled acute pain, which may result in delayed functional recovery, and may progress to chronic pain. Multimodal opioid-sparing analgesia regimens are a key component of the thoracic surgery enhanced recovery pathway, the aim of which is to improve outcomes in patients undergoing both minimally invasive and open thoracic surgical procedures. Novel interfascial plane blocks are emerging as feasible alternatives to central neuraxial analgesia techniques in a variety of clinical settings. The aim of this study is to show non-inferiority of serratus anterior blockade compared with surgically placed paravertebral blocks in the management of perioperative acute pain in patients undergoing VATS procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

September 27, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 7, 2018

Completed
Last Updated

December 7, 2018

Status Verified

December 1, 2018

Enrollment Period

11 months

First QC Date

September 27, 2018

Last Update Submit

December 5, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Opioid consumption

    Expressed as oral morphine equivalent

    Over the first 48 hours postoperatively

Secondary Outcomes (9)

  • Postoperative numerical pain scores

    Over the first 48 hours postoperatively

  • Opioid side - effects - 1

    Over the first 48 hours postoperatively

  • Opioid side - effects - 2

    Over the first 48 hours postoperatively

  • Opioid side - effects - 3

    Over the first 48 hours postoperatively

  • Mean arterial blood pressure

    Over the first 48 hours postoperatively.

  • +4 more secondary outcomes

Study Arms (2)

Deep serratus anterior plane block

EXPERIMENTAL

Ultrasound-guided deposition of 40mls of 2mg/ kg levobupivacaine into the deep serratus anterior plane space, in the mid axillary line, at the level of the 4th/5th rib. Insertion of a continuous local anaesthetic infusion catheter(Portex™) and continuation of an infusion of 0.125% levobupivacaine at a rate of 8-12mls/ hour for 48 hours.

Procedure: Deep serratus anterior plane block

Surgically-placed paravertebral block

ACTIVE COMPARATOR

Surgical placement of paravertebral local anaesthetic infusion catheters (Portex™) prior to closure. Bolus of levobupivacaine as per protocol. Continuation of an infusion of 0.125% levobupivacaine at a rate of 8-12mls/ hour for 48 hours.

Procedure: Surgically-placed paravertebral block

Interventions

Deposition of local anaesthetic in the space between the serratus anterior muscle and the external intercostal muscle, at the level of the 4th-5th rib, in the midaxillary line. Procedure performed under ultrasound guidance. Catheter - based infusion of local anaesthetic into this space for 48 hours.

Deep serratus anterior plane block

Surgically-placed paravertebral block catheters for continuous local anaesthetic infusion of 0.125% levobupivacaine at 8-12mls/ hr for 48 hours.

Surgically-placed paravertebral block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adults greater than or equal to 18 years of age presenting for minimally-invasive thoracic surgery.

You may not qualify if:

  • Patient refusal.
  • Local infection at site of insertion.
  • Allergy to amide local anaesthetics, opioids, paracetamol, NSAIDs, ketamine, NMBs, volatile anaesthetics.
  • Concurrent use of antiarrhythmics with local anaesthetic activity.
  • Concurrent use of MAOIs or within 2 weeks of MAOI use.
  • Severe renal, liver or cardiac dysfunction.
  • Coagulopathy/ anticoagulants that preclude use of PVB/ SAP techniques.
  • Inability to comprehend pain scoring system.
  • Elderly or frail patients that require a reduction in levobupivacaine dose commensurate with their physical status, resulting in the protocol not being followed.
  • Pregnancy, breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mater Misericordiae University Hospital

Dublin, Dublin 7, Ireland

Location

Related Publications (1)

  • Hanley C, Wall T, Bukowska I, Redmond K, Eaton D, Ni Mhuircheartaigh R, Hearty C. Ultrasound-guided continuous deep serratus anterior plane block versus continuous thoracic paravertebral block for perioperative analgesia in videoscopic-assisted thoracic surgery. Eur J Pain. 2020 Apr;24(4):828-838. doi: 10.1002/ejp.1533. Epub 2020 Jan 30.

MeSH Terms

Conditions

Thoracic DiseasesRib FracturesPain, PostoperativePain, Procedural

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesFractures, BoneWounds and InjuriesThoracic InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Conor Hearty, FFPMCAI,FFPMANZCA,FCARCSI,FIPP

    Consultant Anaesthetist, Mater Misericordiae University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Anaesthetist

Study Record Dates

First Submitted

September 27, 2018

First Posted

December 7, 2018

Study Start

October 4, 2017

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

December 7, 2018

Record last verified: 2018-12

Locations